Promethazine and Kalbitor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Promethazine (promethazine hydrochloride) and Kalbitor (ecallantide). Common drug interactions include hereditary angioedema among females and hereditary angioedema among males.

The phase IV clinical study analyzes what interactions people have when they take Promethazine and Kalbitor. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Promethazine?

Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.

What is Kalbitor?

Kalbitor has active ingredients of ecallantide. eHealthMe is studying from 2,079 Kalbitor users. Check the latest studies of Kalbitor.



On Aug, 09, 2026

23 people who take Promethazine and Kalbitor together, and have interactions are studied.

Promethazine and Kalbitor drug interactions.

What are the common drug interactions of Promethazine and Kalbitor, by gender? *:

female:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Headache (pain in head)
  3. Chest injury
  4. Drug ineffective
  5. Fall
  6. Laryngeal oedema (swelling of larynx)
  7. Neuropathy peripheral (surface nerve damage)
  8. Infusion related reaction
  9. Stress
  10. Weight decreased

male:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Influenza
  3. Hyperhidrosis (abnormally increased sweating)
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Pain
  6. Pain in extremity
  7. Abdominal pain
  8. Angioedema (rapid swelling of the dermis)
  9. Asthma
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the common drug interactions of Promethazine and Kalbitor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Influenza
  3. Pelvic fluid collection

20-29:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Pregnancy
  3. Dehydration (dryness resulting from the removal of water)
  4. Hyperemesis gravidarum (a condition characterized by severe nausea, vomiting, weight loss, and electrolyte disturbance)
  5. Maternal exposure during pregnancy (use of substance during pregnancy)

30-39:

  1. Aspartate aminotransferase increased
  2. Blood alkaline phosphatase increased
  3. Blood cholesterol decreased
  4. Haemoglobin decreased
  5. Hereditary angioedema (recurrent episodes of severe swelling)
  6. Abdominal discomfort
  7. Abdominal distension
  8. Drug ineffective
  9. Feeding disorder (when children refuse to eat certain food groups)
  10. Pain

40-49:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Chills (felling of cold)
  3. Hyperhidrosis (abnormally increased sweating)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Pain in extremity
  7. Liposarcoma (a cancer tumour that arises in fat cells in deep soft tissue)
  8. Post procedural infection

50-59:

  1. Pneumonia

60+:

  1. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  2. Headache (pain in head)
  3. Hereditary angioedema (recurrent episodes of severe swelling)
  4. Oxygen saturation decreased
  5. Swollen tongue (swelling of tongue)
  6. Cough
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Pneumonia
  9. Pyrexia (fever)

What are the existing conditions these people have? *

  1. Hereditary Angioedema (recurrent episodes of severe swelling): 19 people, 82.61%
  2. Immune System Disorder: 6 people, 26.09%
  3. Stress And Anxiety: 2 people, 8.70%
  4. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Promethazine and Kalbitor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Promethazine and Kalbitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Promethazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kalbitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Promethazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kalbitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on promethazine hydrochloride and ecallantide (the active ingredients of Promethazine and Kalbitor, respectively), and Promethazine and Kalbitor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: